Nautilus Biotechnology (NAUT) Other Working Capital Changes (2020 - 2026)
Nautilus Biotechnology (NAUT) reported Other Working Capital Changes of -$1.1 million for Q1 2026, down 0.79% on a YoY basis from -$1.2 million in Q1 2025, and down 127.29% sequentially from $4.2 million in Q4 2025.
Nautilus Biotechnology (NAUT) Other Working Capital Changes (2020 - 2026) Analysis & Trends
Nautilus Biotechnology (NAUT) has 7 years of Other Working Capital Changes data on file, last reported at -$1.1 million in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes fell 0.79% year-over-year to -$1.1 million; the trailing twelve-month figure through Mar 2026 stood at $716000.0 (up 116.73% YoY), and the FY2025 full-year result was -$4.7 million, down 12.96% from the prior year.
- Other Working Capital Changes slipped to -$1.1 million in Q1 2026, from $4.2 million in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $1.1 million in Q2 2022 to a low of -$742000.0 in Q3 2022.
- A 5-year average of -$46470.6 and a median of -$45000.0 in 2024 frame the typical range for Other Working Capital Changes.
- Across the five-year window, Other Working Capital Changes slumped 3022.22% in 2023 and jumped 485.67% in 2025, its largest moves.
- Tracing NAUT's Other Working Capital Changes over 5 years: stood at -$527000.0 in 2022, then slumped by 91.27% to -$1.0 million in 2023, then declined by 8.04% to -$1.1 million in 2024, then jumped by 485.67% to $4.2 million in 2025, then plunged by 127.29% to -$1.1 million in 2026.
- Business Quant data shows NAUT's Other Working Capital Changes at -$1.1 million in Q1 2026, $4.2 million in Q4 2025, and -$1.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Nautilus Biotechnology | 224.14 Mn | 224.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 355,000.00 |
| Mar 31, 2026 | 355,000.00 |
| Mar 31, 2026 | 355,000.00 |
| Dec 31, 2025 | -395,000.00 |
| Dec 31, 2025 | -395,000.00 |
| Dec 31, 2025 | -395,000.00 |
| Sep 30, 2025 | 11,000.00 |
| Sep 30, 2025 | 11,000.00 |
| Sep 30, 2025 | 11,000.00 |
| Jun 30, 2025 | 7,000.00 |
| Jun 30, 2025 | 7,000.00 |
| Jun 30, 2025 | 7,000.00 |
| Mar 31, 2025 | -167,000.00 |
| Mar 31, 2025 | -167,000.00 |
| Mar 31, 2025 | -167,000.00 |
| Dec 31, 2024 | -692,000.00 |
| Dec 31, 2024 | -692,000.00 |
| Dec 31, 2024 | -692,000.00 |
| Sep 30, 2024 | -45,000.00 |
| Sep 30, 2024 | -45,000.00 |